Concomitant Chemoradiotherapy (CT/RT) or CETUXIMAB/RT (CET/RT) with or Without Induction Docetaxel/Cisplatin/5-Fluorouracil (TPF) in Locally Advanced Head and Neck Cancer (LASCCHN). Preliminary Toxicity Results of a Randomized, 2x2 Factorial, Phase II-III Study. (NCT01086826)

Concomitant chemoradiotherapy (CT/RT) vs neoadjuvant chemotherapy with docetaxel/cispaltin/5-fluorouracil (TPF) followed by CT/RT in locally advanced head and neck cancer. Final results of a phase II randomized study

10.1200/jco.2008.26.15_suppl.6000 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 6000-6000 ◽

Cited By ~ 13

Author(s):

A. Paccagnella ◽

A. Buffoli ◽

H. Koussis ◽

A. Gava ◽

T. Franceschi ◽

...

Keyword(s):

Head And Neck Cancer ◽

Neoadjuvant Chemotherapy ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Randomized Study ◽

Locally Advanced ◽

Advanced Head ◽

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2015.09.024 ◽

2016 ◽

Vol 52 ◽

pp. 77-84 ◽

Cited By ~ 23

Author(s):

C.M.L. Driessen ◽

J.P. de Boer ◽

H. Gelderblom ◽

C.R.N. Rasch ◽

M.A. de Jong ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Head ◽

Concomitant Chemoradiotherapy ◽

Randomized Phase Ii

Faculty Opinions recommendation of Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2726956.2389054 ◽

2010 ◽

Author(s):

Athanassios Argiris ◽

Michalis Karamouzis

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Randomized Study ◽

Locally Advanced ◽

Advanced Head ◽

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

Annals of Oncology ◽

10.1093/annonc/mdp573 ◽

2010 ◽

Vol 21 (7) ◽

pp. 1515-1522 ◽

Cited By ~ 124

Author(s):

A. Paccagnella ◽

M.G. Ghi ◽

L. Loreggian ◽

A. Buffoli ◽

H. Koussis ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Randomized Study ◽

Locally Advanced ◽

Advanced Head ◽

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

Auris Nasus Larynx ◽

10.1016/j.anl.2010.05.012 ◽

2011 ◽

Vol 38 (1) ◽

pp. 108-113 ◽

Cited By ~ 5

Author(s):

Imjai Chitapanarux ◽

Vicharn Lorvidhaya ◽

Ekasit Tharavichitkul ◽

Somvilai Mayurasakorn ◽

Pichit Sittitrai ◽

...

Keyword(s):

Radiation Therapy ◽

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy145 ◽

2018 ◽

Vol 49 (1) ◽

pp. 37-41 ◽

Cited By ~ 1

Author(s):

Takashi Matsuzuka ◽

Naomi Kiyota ◽

Junki Mizusawa ◽

Tetsuo Akimoto ◽

Masato Fujii ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Clinical Impact ◽

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

Cancer ◽

10.1002/cncr.24525 ◽

2009 ◽

Vol 115 (19) ◽

pp. 4514-4523 ◽

Cited By ~ 56

Author(s):

Robert Haddad ◽

Stephen Sonis ◽

Marshall Posner ◽

Lori Wirth ◽

Rosemary Costello ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Phase 2 ◽

Concomitant Chemoradiotherapy ◽

Phase 2 Study ◽

Randomized Phase 2

Induction chemotherapy (IC) and concomitant chemoradiotherapy (CCRT) for locally advanced head and neck cancer (LAHNC)

10.1200/jco.2005.23.16_suppl.5600 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5600-5600

Author(s):

D. Ferrari ◽

B. Jerekzec-Fossa ◽

F. Chiesa ◽

A. Rocca ◽

M. Ansarin ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin for locally advanced head and neck cancer: A preliminary result

10.1200/jco.2005.23.16_suppl.5587 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5587-5587

Author(s):

J. G. Kim ◽

J. H. Baek ◽

S. K. Sohn ◽

D. H. Kim ◽

S. B. Jeon ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Study ◽

Locally Advanced ◽

Phase II/III trial of induction chemotherapy (ICT) with cisplatin/5-fluorouracil (PF) vs. docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs. CRT for unresectable locally advanced head and neck cancer (LAHNC)

10.1200/jco.2005.23.16_suppl.5578 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5578-5578 ◽

Cited By ~ 7

Author(s):

R. Hitt ◽

J. Grau ◽

A. Lopez-Pousa ◽

A. Berrocal ◽

J. Sastre ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Neck Cancer ◽

Locally Advanced ◽